Your shopping cart is currently empty

Vimnerixin (AZD4721) is an orally administered CXCR2 antagonist for inflammation studies.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $399 | - | In Stock |
| Description | Vimnerixin (AZD4721) is an orally administered CXCR2 antagonist for inflammation studies. |
| In vitro | Vimnerixin (RIST4721) inhibited KC-stimulated chemotaxis in a dose-dependent manner. Vimnerixin at 10 nM and 100 nM significantly suppressed chemotaxis, while the inhibitory effect at 1 nM was not evident. Vimnerixin at 1 μM completely blocked KC-induced chemotaxis. |
| In vivo | In preclinical studies, Vimnerixin underwent systematic pharmacokinetic evaluation in male Sprague-Dawley (SD) rats and beagle dogs via intravenous injection (1 mg/kg) and oral administration, with bile duct cannulation (BDC) experiments conducted to assess its excretion pathways. The results demonstrated that Vimnerixin exhibited low clearance rates (2.4 ml/min/kg in rats, 0.5 ml/min/kg in dogs), low volume of distribution (0.15–0.19 L/kg), and prolonged half-life (3.7 hours for intravenous administration in dogs, extending to 8.4 hours for oral administration). The plasma concentration-time curves were highly consistent between bile-duct-cannulated and non-cannulated groups, indicating minimal influence from enterohepatic circulation. |
| Synonyms | RIST4721, RIST 4721, AZD4721, AZD 4721 |
| Molecular Weight | 472.55 |
| Formula | C19H25FN4O5S2 |
| Cas No. | 1418112-77-2 |
| Smiles | N(S(=O)(=O)N1CC(C)C1)C=2C=C(O[C@@H]([C@H](CO)O)C)N=C(SCC3=CC=C(F)C=C3)N2 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (169.29 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.